- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
FDA Backs Pfizer Booster for Seniors, Others at High Risk for Serious COVID-19
The next step is for the CDC's Advisory Committee on Immunization Practices to make a decision on whether to add a COVID-19 booster to its recommendations
‘
As expected, the FDA has come out in a favor of a Pfizer COVID-19 vaccine shoot for people ages 65 and older and adults in highr isk groups
The agency followed the advice of an outside advisory committee, the Vaccines and Related Biological Products Advisory Committee, that voted last week for more limited use of the booster shot than had been envisioned by the Biden administration.
The FDA announced this evening that the agency had extended an emergency use authorization (EUA) for the Pfizer vaccine to allow a single booster shot to be given. The FDA said the booster shouldn’t be given till at least six months after the initial two-shot series of the Pfizer vaccine has been completed.
The drug regulator said booster can be given to people in three groups:
- Those 65 and older
- Adults, ages 18 to 64, who are at high-risk for suffering a severe case of COVID-19
- Adults, ages 18 to 64, whose “frequent institutional or occupational exposure” toration the SARS-CoV-2 virus puts them at high risk of serious complications of COVID-19.
This summer, Biden administration floated the idea of all adults getting a booster, although it also indicated that it would follow the decisions of the and CDC.
The FDA’s EUA doesn’t set federal vaccine policy; the CDC’s Advisory Committee on Immunization Practices (ACIP) does. The ACIP committee met today to discuss the booster shoot and is scheduled to meet again tomorrow. According to the Associated Press, some of the members of the committee suggested putting off a decision for a month in hopes that more definitive evidence about the booster will become available.
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
Virtual Urgent Care's Slight Impact on Emergency Visits During the COVID-19 Pandemic
November 7th 2023A recent study revealed that virtual urgent care (VUC) had minimal impact on emergency department visits or hospital admissions in Ontario, Canada, during the COVID-19 pandemic. However, a significant number of study participants who initially sought virtual urgent care eventually attended an emergency department in person.
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
Prevalence of COVID-19 and Transmission Between Childcare Centers, Households is Low, Study Finds
October 26th 2023Authors of a recent JAMA Network Open study expressed there have been few reported COVID surveillance studies of childcare centers and none in the U.S. Authors stress that it's essential for policymakers to understand the real risk of COVID spread in CCCs and households so they can apply suitable mitigation measures if there were to be another surge or new variants to come about.
Read More
The Latest on Long COVID — Most Prevalent Symptoms to Research Underway | IDWeek 2023
October 12th 2023At this year’s ID Week conference in Boston, Igho Ofotokun, MD, MSc, FIDSA, Grady Distinguished Professor of Medicine at the Emory University School of Medicine, shared the latest data that COVID-19 research team, RECOVER, has gathered on Long COVID and its symptoms.
Read More
